SCHEMBL3401302

SCHEMBL3401302

Cc1nc(-c2ccc(F)c(Cl)c2)sc1C(=O)NCCC1CCCN1C

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 4/20 0.53
CHRM3 P20309 8/20 0.49
ACKR3 P25106 2/20 0.48
PPARA Q07869 5/20 0.46
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
CHRNB1 P11230 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNB3 Q05901 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399661 0.93 CHRM4 (0.53) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL3402461 0.92 CHRM4 (0.55) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL13309884 0.92 CHRM4 (0.51) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL3405722 0.89 CHRM4 (0.50) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL3405413 0.87 CHRM4 (0.53) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL3405145 0.86 CHRM4 (0.52) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL3403904 0.86 CHRM4 (0.47) CHRM4CHRM3ACKR3PPARAPPARD
SCHEMBL3404888 0.86 CHRM4 (0.53) CHRM4CHRM3ACKR3PPARAPPARG
SCHEMBL3403460 0.85 CHRM4 (0.54) CHRM4ACKR3PPARAPPARGPPARD
SCHEMBL3405362 0.85 ACKR3 (0.55) CHRM4ACKR3PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed